Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 31

    1.

    Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk.

    Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X.

    Int J Cancer. 2012 Jan 19. doi: 10.1002/ijc.27437. [Epub ahead of print]

    PMID:
    22261697
    [PubMed - as supplied by publisher]
    2.

    Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.

    Ha YS, Kim JS, Yoon HY, Jeong P, Kim TH, Yun SJ, Lee SC, Kim GY, Choi YH, Moon SK, Yi Kim I, Kim WJ.

    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27319. [Epub ahead of print]

    PMID:
    22025348
    [PubMed - as supplied by publisher]
    3.

    Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells.

    Tatokoro M, Koga F, Yoshida S, Kawakami S, Fujii Y, Neckers L, Kihara K.

    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26475. [Epub ahead of print]

    PMID:
    21964864
    [PubMed - as supplied by publisher]
    4.

    Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.

    Szarvas T, László V, Vom Dorp F, Reis H, Szendröi A, Romics I, Tilki D, Rübben H, Ergün S.

    Int J Cancer. 2012 Jun 15;130(12):2922-9. doi: 10.1002/ijc.26343. Epub 2011 Sep 22.

    PMID:
    21815140
    [PubMed - in process]
    5.

    The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.

    Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A.

    Int J Cancer. 2011 Jul 15;129(2):346-54. doi: 10.1002/ijc.25700. Epub 2010 Dec 1.

    PMID:
    20878954
    [PubMed - indexed for MEDLINE]
    6.

    MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.

    Vinall RL, Ripoll AZ, Wang S, Pan CX, deVere White RW.

    Int J Cancer. 2012 Jun 1;130(11):2526-38. doi: 10.1002/ijc.26256. Epub 2011 Dec 2.

    PMID:
    21702042
    [PubMed - indexed for MEDLINE]
    7.

    Hair dye use and risk of bladder cancer in the New England bladder cancer study.

    Koutros S, Silverman DT, Baris D, Zahm SH, Morton LM, Colt JS, Hein DW, Moore LE, Johnson A, Schwenn M, Cherala S, Schned A, Doll MA, Rothman N, Karagas MR.

    Int J Cancer. 2011 Dec 15;129(12):2894-904. doi: 10.1002/ijc.26245. Epub 2011 Aug 12.

    PMID:
    21678399
    [PubMed - indexed for MEDLINE]
    8.

    Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.

    Karam JA, Huang S, Fan J, Stanfield J, Schultz RA, Pong RC, Sun X, Mason RP, Xie XJ, Niu G, Chen X, Frenkel EP, Sagalowsky AI, Hsieh JT.

    Int J Cancer. 2011 Jun 15;128(12):2823-32. doi: 10.1002/ijc.25631. Epub 2010 Oct 26.

    PMID:
    20734393
    [PubMed - indexed for MEDLINE]
    9.

    Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC).

    Ros MM, Bas Bueno-de-Mesquita HB, Büchner FL, Aben KK, Kampman E, Egevad L, Overvad K, Tjønneland A, Roswall N, Clavel-Chapelon F, Kaaks R, Chang-Claude J, Boeing H, Weikert S, Trichopoulou A, Orfanos P, Stasinopulou G, Saieva C, Krogh V, Vineis P, Tumino R, Mattiello A, Peeters PH, van Duijnhoven FJ, Lund E, Gram IT, Chirlaque MD, Barricarte A, Rodríguez L, Molina E, Gonzalez C, Dorronsoro M, Manjer J, Ehrnström R, Ljungberg B, Allen NE, Roddam AW, Khaw KT, Wareham N, Boffetta P, Slimani N, Michaud DS, Kiemeney LA, Riboli E.

    Int J Cancer. 2011 Jun 1;128(11):2695-708. doi: 10.1002/ijc.25592. Epub 2010 Oct 8.

    PMID:
    20715171
    [PubMed - indexed for MEDLINE]
    10.

    Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.

    Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S.

    Int J Cancer. 2012 Mar 1;130(5):1109-19. doi: 10.1002/ijc.26123. Epub 2011 Jun 21.

    PMID:
    21480223
    [PubMed - indexed for MEDLINE]
    11.

    Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.

    Tao L, Xiang YB, Chan KK, Wang R, Gao YT, Yu MC, Yuan JM.

    Int J Cancer. 2012 Mar 1;130(5):1174-83. doi: 10.1002/ijc.26121. Epub 2011 Jun 21.

    PMID:
    21480221
    [PubMed - indexed for MEDLINE]
    12.

    LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese.

    Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, Gao YT, Nelson HH, Kelsey KT.

    Int J Cancer. 2012 Mar 1;130(5):1151-9. doi: 10.1002/ijc.26098. Epub 2011 May 25.

    PMID:
    21445976
    [PubMed - indexed for MEDLINE]
    13.

    Cigarette smoking and subtypes of bladder cancer.

    Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, Pike MC, Gago-Dominguez M.

    Int J Cancer. 2012 Feb 15;130(4):896-901. doi: 10.1002/ijc.26068. Epub 2011 May 9.

    PMID:
    21412765
    [PubMed - indexed for MEDLINE]
    14.

    Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.

    Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, Raney RB, Jenney ME, Brecht IB, Koscielniak E, Carli M, Bisogno G, Oberlin O, Rey A, Ullrich F, Stevens MC, Meyer WH.

    Int J Cancer. 2011 Mar 1;128(5):1232-9. doi: 10.1002/ijc.25444.

    PMID:
    20473932
    [PubMed - indexed for MEDLINE]
    15.

    P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma.

    Van Marck V, Stove C, Jacobs K, Van den Eynden G, Bracke M.

    Int J Cancer. 2011 Mar 1;128(5):1031-44. doi: 10.1002/ijc.25427.

    PMID:
    20473917
    [PubMed - indexed for MEDLINE]
    16.

    The importance of integrin-linked kinase in the regulation of bladder cancer invasion.

    Matsui Y, Assi K, Ogawa O, Raven PA, Dedhar S, Gleave ME, Salh B, So AI.

    Int J Cancer. 2012 Feb 1;130(3):521-31. doi: 10.1002/ijc.26008. Epub 2011 May 28.

    PMID:
    21351095
    [PubMed - indexed for MEDLINE]
    17.

    Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.

    Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R.

    Int J Cancer. 2011 Feb 1;128(3):562-73.

    PMID:
    20473859
    [PubMed - indexed for MEDLINE]
    18.

    Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.

    Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsunoda T, Field HI, Neal DE, Yamaue H, Ponder BA, Nakamura Y, Hamamoto R.

    Int J Cancer. 2011 Feb 1;128(3):574-86.

    PMID:
    20333681
    [PubMed - indexed for MEDLINE]
    19.

    Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.

    Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Sato S, Mitobe Y, Narita S, Habuchi T.

    Int J Cancer. 2010 Dec 10. [Epub ahead of print]

    PMID:
    21154810
    [PubMed - as supplied by publisher]
    20.

    Expression of laminin gamma2 chain monomer enhances invasive growth of human carcinoma cells in vivo.

    Tsubota Y, Ogawa T, Oyanagi J, Nagashima Y, Miyazaki K.

    Int J Cancer. 2010 Nov 1;127(9):2031-41.

    PMID:
    20143393
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk